Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,208 | 211,988 | 247,698 | 260,126 | 100,554 |
| Marketable Securities | 163,903 | 19,030 | 24,083 | 54,055 | 61,959 |
| Receivables | 744 | 1,340 | 2,083 | 1,969 | 815 |
| TOTAL | $214,738 | $235,617 | $282,453 | $321,907 | $169,684 |
| Non-Current Assets | |||||
| PPE Net | 53,427 | 55,404 | 56,552 | 57,850 | 58,754 |
| Intangibles | 98,100 | 79,355 | 25,798 | 25,798 | 25,798 |
| Other Non-Current Assets | 619 | 497 | 352 | 3,656 | 3,525 |
| TOTAL | $152,146 | $135,256 | $82,702 | $87,304 | $88,077 |
| Total Assets | $366,884 | $370,873 | $365,155 | $409,211 | $257,761 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,138 | 1,114 | 17,100 | 36,599 | 38,482 |
| Accounts payable and accrued liabilities | 3,159 | 3,550 | 3,547 | 4,773 | 5,919 |
| Accrued Expenses | 6,264 | 7,437 | 6,285 | 5,368 | 5,611 |
| TOTAL | $10,775 | $12,948 | $27,446 | $47,316 | $50,954 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,345 | 27,640 | 27,922 | 28,199 | 28,482 |
| Deferred Revenues | 214 | 847 | 514 | 576 | 942 |
| Other Non-Current Liabilities | 48,783 | 47,219 | 540 | 579 | 616 |
| TOTAL | $109,085 | $89,071 | $42,674 | $42,990 | $43,310 |
| Total Liabilities | $119,860 | $102,019 | $70,120 | $90,306 | $94,264 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,247 | 48,238 | 48,215 | 48,215 | 25,098 |
| Common Shares | 338 | 338 | 338 | 338 | 176 |
| Retained earnings | -673,406 | -650,407 | -622,894 | -597,701 | -570,175 |
| Other shareholders' equity | -232 | -238 | -237 | -237 | -378 |
| TOTAL | $247,024 | $268,854 | $295,035 | $318,905 | $163,497 |
| Total Liabilities And Equity | $366,884 | $370,873 | $365,155 | $409,211 | $257,761 |